Our curated bond selection

See which bonds we like and why

How we select bonds
VW Leasing 4.75% Sep 2031
VW Leasing
4,75% Sep 2031
Yield: 3,46% EUR
ONEOK 6.1% Nov 2032
ONEOK
6,1% Nov 2032
Yield: 5,33% USD
Fresenius 5.125% Oct 2030
Fresenius
5,13% Oct 2030
Yield: 3,01% EUR
Telecom IT Fin 7.75% Jan 2033
Telecom IT Fin
7,75% Jan 2033
Yield: 3,77% EUR
Hungary 5.375% Sep 2033
Hungary
5,38% Sep 2033
Yield: 4,48% EUR
RCI Banque 4.875% Oct 2029
RCI Banque
4,88% Oct 2029
Yield: 3% EUR
Want to see more highlights?
Unlock insignts about 4,000 bonds
Sign Up
Author

Fresenius 5.125% Oct 2030

Buy and Hold
High Coupon
Loading bond...
Currency
EUR
Country
Germany
Industry
Healthcare Providers & Services
Yield
3,01 %
Term
5,35 years
Brokers
ING GermanyInteractive BrokersTrade Republic
Min. amount
1000 EUR
Deposit spread
1,41 %
Market risk
Credit risk

Issuer overview

POSTPK-NeueHeliosHSK-Aussenansicht.jpg Helios HSK's hospital in Wiesbaden, Germany

Publication date: 15-05-2025

Fresenius SE & Co. KGaA is a Germany-based global healthcare company with leading positions in hospital operations, biopharmaceuticals, and clinical nutrition. The group operates through two core segments: Fresenius Helios, Europe’s largest private hospital operator, and Fresenius Kabi, which focuses on injectable generics, clinical nutrition, and medical devices.

These two business lines are largely uncorrelated, providing resilience across economic cycles. Together, they generate a high share of recurring revenues, supported by long-term demand for healthcare services and essential medicines.

Fresenius remains committed to maintaining leverage within its publicly stated target range. While some healthcare providers face margin pressure from tariff changes and input costs, the company expects tariff impacts to be limited. This is due to its substantial U.S. footprint and strong local manufacturing base.

Issuer Financials

as of 31.03.2025 EUR bn

Column 1 Column 2 Column 3 Column 4 Column 5 Column 6
Assets 43,6 EBITDA Margin 14 % CFO/Debt 0,2
Revenue 21,8 Net debt 10,4 FCF 1,6
EBITDA 3,1 Net Debt/EBITDA 4x Equity 20,3
Net Profit 0,5 EBITDA/Interest 5x Debt/Equity 0,6x
22,2 EUR bn
Market cap
on 31.03.2025

Key points

Un-blur this bond
Sign up to access full information about the bond
Sign-up
Author
Stanislav Polezhaev, CFA
Stanislav, a capital markets expert with 10+ years in fixed income, led 50+ professionals at a top CIS investment bank, focusing on global bond opportunities.
Author

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. Bondfish is not an investment adviser, financial adviser or a broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by Bondfish to buy, sell or hold any security or financial product, and Bondfish makes no representation (and has no opinion) regarding the advisability or suitability of any investment. Mention of specific financial products or operations does not constitute an endorsement by Bondfish.

The financial products or operations referred to in such data and information may not be suitable for your investment profile and investment objectives or expectations. It is your responsibility to consider whether any financial product or operation is suitable for you based on your interests, investment objectives, investment horizon and risk appetite. Bondfish shall not be liable for any damages arising from any operations or investments in financial products referred to within. Bondfish does not recommend using the data and information provided as the only basis for making any investment decision.

This data is not updated in real time and represents the prices available at the end of the previous trading day. Bondfish does not verify any data and disclaims any obligation to do so. Bondfish expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects therein, delays or interruptions in such data, or for any actions taken in reliance thereon. Bondfish shall not be liable for any damages relating to your use of the information provided herein.

Past performance is not a reliable indicator of future results.

Translate
Warning! The translation is automatic and may contain errors.